JP2023509973A5 - - Google Patents

Info

Publication number
JP2023509973A5
JP2023509973A5 JP2022542247A JP2022542247A JP2023509973A5 JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5 JP 2022542247 A JP2022542247 A JP 2022542247A JP 2022542247 A JP2022542247 A JP 2022542247A JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5
Authority
JP
Japan
Prior art keywords
sequence
antibody
cancer
antigen
sequence shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022542247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2021/050009 external-priority patent/WO2021141492A1/en
Publication of JP2023509973A publication Critical patent/JP2023509973A/ja
Publication of JP2023509973A5 publication Critical patent/JP2023509973A5/ja
Pending legal-status Critical Current

Links

JP2022542247A 2020-01-10 2021-01-08 上皮カドヘリン特異性抗体 Pending JP2023509973A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20151325 2020-01-10
EP20151325.6 2020-01-10
PCT/NL2021/050009 WO2021141492A1 (en) 2020-01-10 2021-01-08 Epithelial cadherin-specific antibodies

Publications (2)

Publication Number Publication Date
JP2023509973A JP2023509973A (ja) 2023-03-10
JP2023509973A5 true JP2023509973A5 (https=) 2024-01-17

Family

ID=69159601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542247A Pending JP2023509973A (ja) 2020-01-10 2021-01-08 上皮カドヘリン特異性抗体

Country Status (11)

Country Link
US (1) US20240317880A1 (https=)
EP (1) EP4087872A1 (https=)
JP (1) JP2023509973A (https=)
KR (1) KR20220131527A (https=)
CN (2) CN115066439A (https=)
AU (1) AU2021206586A1 (https=)
BR (1) BR112022013601A2 (https=)
CA (1) CA3163286A1 (https=)
IL (1) IL294342A (https=)
MX (1) MX2022008391A (https=)
WO (1) WO2021141492A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681581A (en) 1983-12-05 1987-07-21 Coates Fredrica V Adjustable size diaper and folding method therefor
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US5101827A (en) 1985-07-05 1992-04-07 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4735210A (en) 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US5648471A (en) 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
DK0486622T3 (da) 1989-08-09 1999-07-19 Rhomed Inc Direkte radiomærkning af antistoffer og andre proteiner med technetium eller rhenium
WO2010087994A2 (en) 2009-01-30 2010-08-05 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
AU2011319777B2 (en) * 2010-10-27 2016-12-08 The Research Foundation For The State University Of New York Compositions targeting the soluble extracellular domain of E-cadherin and related methods for cancer therapy
ES2931477T3 (es) * 2010-10-29 2022-12-29 Perseus Proteomics Inc Anticuerpo anti-CDH3 que tiene alta capacidad de internalización
KR102276528B1 (ko) * 2011-09-30 2021-07-12 추가이 세이야쿠 가부시키가이샤 이온 농도 의존성 결합 분자 라이브러리
EP2785737A2 (en) 2011-12-02 2014-10-08 AIMM Therapeutics B.V. Influenza a virus specific antibodies
US9534058B2 (en) * 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
SG11201601424PA (en) * 2013-08-28 2016-03-30 Stemcentrx Inc Site-specific antibody conjugation methods and compositions
WO2015093949A2 (en) 2013-12-17 2015-06-25 Aimm Therapeutics B.V. Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
AU2016356780A1 (en) * 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Similar Documents

Publication Publication Date Title
JP7583707B2 (ja) 抗cd47抗体及びその応用
JP7461950B2 (ja) Cd3抗体およびその医薬用途
JP2021514664A5 (https=)
CN112574307A (zh) 抗人Claudin18.2抗体及其应用
CA3118775A1 (en) Anti-cd73 antibody, antigen-binding fragment thereof and application thereof
CN112969476B (zh) 多特异性蛋白分子
CN115052896A (zh) 抗ror1抗体和组合物
EP4393950A1 (en) Fap/cd40 binding molecule and medicinal use thereof
JP2021528047A5 (https=)
CN113683697B (zh) 抗b7-h3抗体、其制备方法及用途
CN114181310A (zh) 抗tigit抗体、其药物组合物及用途
TWI797609B (zh) 抗pd-1和pd-l1的四價雙特異性抗體
CN113563473A (zh) 四价双特异性抗体、其制备方法和用途
JP2024001073A5 (https=)
WO2023104080A1 (zh) 抗trop-2抗体或其抗原结合片段
WO2024114676A1 (zh) Cldn18.2/4-1bb结合蛋白及其医药用途
JP2023525991A5 (https=)
US10781265B2 (en) Humanized antibodies against Globo H and uses thereof in cancer treatments
CN112805297B (zh) 抗人类pd-l1抗体及其用途
WO2025016459A1 (zh) 一种抗fgfr2/pd-1双特异性抗体
JP2023509973A5 (https=)
CN116813786B (zh) 抗cd73抗体及其应用
CN113754774A (zh) 一种抗pd-l1和egfr的四价双特异性抗体
WO2024131846A1 (en) Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
CN115073596B (zh) 一种人源化Claudin18.2抗体及其应用